Public Employees Retirement System of Ohio Has $201,000 Position in BioSpecifics Technologies Corp (BSTC)

Public Employees Retirement System of Ohio raised its position in shares of BioSpecifics Technologies Corp (NASDAQ:BSTC) by 16.2% during the first quarter, Holdings Channel reports. The institutional investor owned 3,674 shares of the biopharmaceutical company’s stock after buying an additional 513 shares during the period. Public Employees Retirement System of Ohio’s holdings in BioSpecifics Technologies Corp were worth $201,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. Bank of Montreal Can increased its stake in BioSpecifics Technologies Corp by 10.6% in the first quarter. Bank of Montreal Can now owns 7,272 shares of the biopharmaceutical company’s stock worth $398,000 after buying an additional 699 shares during the last quarter. State Street Corp increased its stake in BioSpecifics Technologies Corp by 7.9% in the fourth quarter. State Street Corp now owns 82,092 shares of the biopharmaceutical company’s stock worth $4,574,000 after buying an additional 5,981 shares during the last quarter. Strs Ohio increased its stake in BioSpecifics Technologies Corp by 161.7% in the first quarter. Strs Ohio now owns 12,300 shares of the biopharmaceutical company’s stock worth $674,000 after buying an additional 7,600 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in BioSpecifics Technologies Corp by 15.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 229,340 shares of the biopharmaceutical company’s stock worth $12,774,000 after buying an additional 30,210 shares during the last quarter. Finally, Cadence Capital Management LLC increased its stake in BioSpecifics Technologies Corp by 22.2% in the first quarter. Cadence Capital Management LLC now owns 26,615 shares of the biopharmaceutical company’s stock worth $1,459,000 after buying an additional 4,840 shares during the last quarter. 54.97% of the stock is currently owned by institutional investors.

Shares of BioSpecifics Technologies Corp (BSTC) traded down 5.19% on Thursday, hitting $45.70. The company had a trading volume of 12,816 shares. BioSpecifics Technologies Corp has a 12 month low of $35.79 and a 12 month high of $58.79. The company has a 50-day moving average of $49.81 and a 200 day moving average of $51.97. The stock has a market cap of $327.71 million, a PE ratio of 28.04 and a beta of 1.76.

TRADEMARK VIOLATION WARNING: This article was first posted by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/2800438/public-employees-retirement-system-of-ohio-has-201000-position-in-biospecifics-technologies-corp-bstc.html.

Several brokerages recently issued reports on BSTC. HC Wainwright set a $72.00 price objective on BioSpecifics Technologies Corp and gave the stock a “buy” rating in a research report on Thursday. Zacks Investment Research upgraded BioSpecifics Technologies Corp from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. Finally, BidaskClub downgraded BioSpecifics Technologies Corp from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd.

BioSpecifics Technologies Corp Company Profile

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of Endo International plc (Endo), for injectable collagenase for marketed indications and indications in development.

Want to see what other hedge funds are holding BSTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioSpecifics Technologies Corp (NASDAQ:BSTC).

Institutional Ownership by Quarter for BioSpecifics Technologies Corp (NASDAQ:BSTC)

Receive News & Ratings for BioSpecifics Technologies Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSpecifics Technologies Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.